Human and mouse killer-cell inhibitory receptors recruit PTP1C and PtPlD protein tyrosine phosphatases

被引:0
|
作者
Olcese, L
Lang, P
Vely, F
Cambiaggi, A
Marguet, D
Blery, M
Hippen, KL
Biassoni, R
Moretta, A
Moretta, L
Cambier, JC
Vivier, E
机构
[1] CNRS MARSEILLE LUMINY, INSERM, CTR IMMUNOL, F-13288 MARSEILLE 09, FRANCE
[2] UNIV GENOA, INST HIST & GEN EMBRYOL, GENOA, ITALY
[3] NATL JEWISH CTR IMMUNOL & RESP MED, DIV BASIC SCI, DEPT PEDIAT, DENVER, CO 80206 USA
[4] NATL IST CANC RES, GENOA, ITALY
来源
JOURNAL OF IMMUNOLOGY | 1996年 / 156卷 / 12期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NK cells express cell surface receptors for MHC class I proteins (KIR). Engagement of these receptors inhibits NK cell cytotoxic programs. KIR can be expressed on T cells, and their engagement also results in inhibition of effector functions initiated by the CD3/TCR complex. While human KIR genes belong to the Ig gene superfamily, mouse KIR belong to a family of dimeric lectins. Despite these distinct evolutionary origins, we show here that both HLA-Cw3-specific human p58.183 receptors and H-2D(d/k)-specific mouse Ly49A receptors recruit the same protein tyrosine phosphatases, PTP1C and PTP1D, upon phosphorylation of critical intracytoplasmic tyrosine residues. These results document a common pathway by which diverse KIR can down-regulate NK and T cell activation programs, and further define the sequence of the immunoreceptor tyrosine-based inhibitory motif (ITIM), initially described in FC gamma RIIB1, and expressed in both human and mouse KIR.
引用
收藏
页码:4531 / 4534
页数:4
相关论文
共 50 条
  • [1] Association of the protein tyrosine phosphatase PTP1C with the protein tyrosine kinase c-Src in human platelets
    Falet, H
    RamosMorales, F
    Bachelot, C
    Fischer, S
    Rendu, F
    FEBS LETTERS, 1996, 383 (03): : 165 - 169
  • [2] THE PHOSPHOTYROSINE PHOSPHATASE PTP1D, BUT NOT PTP1C, IS AN ESSENTIAL MEDIATOR OF FIBROBLAST PROLIFERATION INDUCED BY TYROSINE KINASE AND G-PROTEIN-COUPLED RECEPTORS
    RIVARD, N
    MCKENZIE, FR
    BRONDELLO, JM
    POUYSSEGUR, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) : 11017 - 11024
  • [3] A possible role for the protein tyrosine phosphate PTP1C during regeneration of the axotomised facial nerve
    Horvat, A
    Schwaiger, FW
    Hager, G
    Streif, R
    Ullrich, A
    Kreutzberg, GW
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 60 - 60
  • [4] Role of a protein tyrosine phosphatase, PTP1C, in Fas (CD95)-induced cytotoxicity
    Takayama, H
    ShirotaSomeya, Y
    FASEB JOURNAL, 1996, 10 (06): : 405 - 405
  • [5] Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase
    Pani, G
    Fischer, KD
    MlinaricRascan, I
    Siminovitch, KA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03): : 839 - 852
  • [6] Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C
    Campbell, KS
    Dessing, M
    LopezBotet, M
    Cella, M
    Colonna, M
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01): : 93 - 100
  • [7] Regulation of T cell activation by β1 integrins:: Involvement of the tyrosine phosphatase SHP-1 (PTP1C).
    Mary, F
    Moon, C
    Venaille, T
    Thomas, ML
    Mary, D
    Bernard, A
    FASEB JOURNAL, 1998, 12 (04): : A577 - A577
  • [8] LCK phosphorylated human killer cell inhibitory receptors recruit and activate phosphatidylinositol 3-kinase.
    Marti, F
    Xu, CW
    Selvakumar, A
    Brent, R
    Dupont, B
    King, PD
    FASEB JOURNAL, 1998, 12 (05): : A903 - A903
  • [9] NEUTROPHILS (PMN) FROM PROTEIN-TYROSINE-PHOSPHATASE 1C (PTP1C)-DEFICIENT MICE DEMONSTRATE ENHANCED TYROSINE PHOSPHORYLATION AND OXIDATIVE BURST
    BUTLER, J
    SIMINOVITCH, K
    GRINSTEIN, S
    DOWNEY, G
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 1301 - 1301
  • [10] IDENTIFICATION OF THE TYROSINE PHOSPHATASE PTP1C AS A B-CELL ANTIGEN RECEPTOR-ASSOCIATED PROTEIN INVOLVED IN THE REGULATION OF B-CELL SIGNALING
    PANI, G
    KOZLOWSKI, M
    CAMBIER, JC
    MILLS, GB
    SIMINOVITCH, KA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06): : 2077 - 2084